Cancer programs in AACR spotlight; Stem cells tested for AMD;

Cancer Research

One group of researchers at AACR have been working with T cells, designing them to attack cancer. That's just one of the examples HealthDay focused on as it explores a range of new projects that took center stage at the scientific conference. "This is an extremely exciting time in cancer research," observed Dr. David Carbone, director of the thoracic oncology center at the Vanderbilt-Ingram Cancer Center in Nashville. "Even in the kinds of cancers that traditionally have been very resistant to therapy, we're starting to see clues of amazing responses and clinical benefits for patients." Report

Array BioPharma announced the presentation of two abstracts detailing positive data for its novel, small molecule ErbB family inhibitor, ARRY-543. Release

Alexandra Miller, a senior scientist at the U.S. Armed Forces Radiobiology Research Institute, says that biphosphonates could prevent radiation-induced leukemia. Report

A new study by the Translational Genomics Research Institute demonstrates how screening tools can be used to identify the right chemotherapy cocktail for cancer patients based on their genetic profiles. Release

Researchers at the Translational Genomics Research Institute (TGen) may have found a way to stop the often-rapid spread of deadly brain tumors. Release

Stem Cell Research

Scientists at University College London and Moorsfield eye hospital are testing a new embryonic stem cell therapy for age-related macular degeneration. Pfizer is expected to announce funding for the project later this week. Report

Scientists in the UK are magnetizing stem cells to see if they can better direct therapies to specific sites in the body. Report

Richard Burt of Northwestern University's Feinberg School of Medicine says that a new stem cell therapy could allow diabetics to forgo insulin injections for months of not years. Story


Researchers in the UK are engaged in a safety trial of a new gene therapy for cystic fibrosis. A full-scale trial will be mounted by the end of next year and Genzyme is expected to pick it up if it proves successful. Report

Researchers have described how a common genetic variation may be involved in the development of prostate cancer. Report

An international team of scientists have discovered how genes are controlled in mammals. Story